Copyright: ©Author(s) 2026.
World J Clin Oncol. Mar 24, 2026; 17(3): 117055
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.117055
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.117055
Table 3 Information about these 13 immune checkpoint genes
| Symbol | Type | Role with immunity |
| VTCN1 | Ligand | Inhibit |
| CD28 | Receptor | Activate |
| ICOS | Receptor | Activate |
| TNFRSF9 | Receptor | Activate |
| CD70 | Ligand | Activate |
| CD27 | Receptor | Activate |
| TNFRSF18 | Receptor | Activate |
| CD209 | Ligand | Two side |
| BTNL3 | Ligand | Two side |
| PDCD1 LG2 | Ligand | Two side |
| IDO1 | Ligand | Inhibit |
| PDCD1 | Receptor | Inhibit |
| BTLA | Receptor | Inhibit |
- Citation: Li SH, Liu ZS, Chen YJ, Li JD, Wei L, Chen YY, Zhang W, Huang ZG, Chen ZD, Chen G, Wei DM, Mo ZN, Deng LL. PIGU overexpression and regulation of cellular biological functions in bladder cancer. World J Clin Oncol 2026; 17(3): 117055
- URL: https://www.wjgnet.com/2218-4333/full/v17/i3/117055.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i3.117055